The most common adverse reactions reported with Susvimo were conjunctival hemorrhage, conjunctival hyperemia, iritis, eye pain, cataract, conjunctival disorder, and vitreous hemorrhage.

The most common ocular side effects included conjunctival hemorrhage, eye pain, vitreous floaters, and increased intraocular pressure, while the most common nonocular side effects included ...

Chronic application of detergent preservatives can lead to chronic lymphocytic infiltration in conjunctival stroma as well as deleterious changes to corneal epithelium and tear film instability.

A cervical cancer drug may elevate the risk of developing ocular surface disease, such as conjunctival scarring and infectious keratitis.

The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.

In addition to the cool guy leader (Omari Hardwick), there’s a quippy shapeshifter (Sam Richardson, who does the best he can with this material, and comes out of Section 31 okay), an “I’m ...

Ensuring sufficient staffing levels in birthing units could help hospitals lower cesarean section rates, according to a study published Jan. 28 in Nursing Outlook. A team led by researchers at New ...

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema. Susvimo is the first and only ...